Axiom Space, Burjeel Holdings Sign Agreement to Conduct Research, Test New Technologies in Space
The organizations are working on sending a suite of medical capabilities to space to further science research on how the human body reacts in microgravity.
Houston(News Desk):: Axiom Space, the leading provider of human spaceflight services and developer of human-rated space infrastructure, and Burjeel Holdings PLC (“Burjeel” or “the Group”), a leading super-specialty healthcare services provider in MENA listed on the Abu Dhabi Securities Exchange (SYMBOL: BURJEEL; ISIN: AEE01119B224), signed a Memorandum of Understanding today to conduct science research and test new technologies in space, forging the beginning of a long-term collaboration aimed at expanding access to microgravity for medical advancements.
The collaboration was officially announced at a signing ceremony held at the Burjeel Institute for Global
Health in New York, attended by Dr. Shamsheer Vayalil, Founder and Chairman of Burjeel Holdings, and
Mr. John Sunil, CEO of Burjeel Holdings.
As their first initiative, Axiom Space and Burjeel are working on sending a suite of medical capabilities to
space to further science research on how the human body reacts in microgravity. The suite consists of
best-in-class technologies used in hospitals and clinics around the world, including Burjeel Holdings’
flagship facility Burjeel Medical City (BMC). The research seeks to study how the microgravity environment affects relevant biomarkers, drug substance quality, and remote health services. Axiom Space astronaut(s) intend to wear and operate these technologies remotely throughout their training,launch, and during Axiom Mission 4 (Ax-4), which is scheduled to launch next spring.
Dr. Lucie Low, Axiom Space Chief Scientist, said: “This partnership with Burjeel Holdings underscores
how Axiom Space is providing opportunities for organizations around the world to conduct medical
research in space. We’re reimagining the way humans live and work in low-Earth orbit by leveraging
microgravity to further our understanding of the human body, while also educating the global community
on how to employ the microgravity environment for advancements in science and technology to benefit
humanity.”
Dr. Shamsheer Vayalil, commented: “Through our groundbreaking partnership with Axiom Space, we
are not only advancing the frontiers of medical innovation in microgravity, but we are also ensuring that
both patients in the UAE and around the globe benefit from next-generation healthcare solutions. This
collaboration aligns seamlessly and supports the UAE’s ambitious vision for space exploration. Just as we
continue to reap the benefits of innovations from the space missions over 50 years ago — transforming
everything from telecommunications to medical imaging — this collaboration represents a commitment to
harnessing the unique environment of space to develop and enhance treatment methodologies.
Ultimately, we are laying the foundation for improved patient outcomes today and for generations to
come.”This partnership sets the foundation for a long-term collaboration between Axiom Space and Burjeel, opening the microgravity environment to new users and space explorers, and elevating Burjeel’s
healthcare innovation ambitions.-(Ends)–